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Nuclear pore complexes (NPCs) are built from 30
different proteins called nucleoporins or Nups. Pre-
vious studies have shown that several Nups exhibit
cell-type-specific expression and that mutations in
NPC components result in tissue-specific diseases.
Here we show that a specific change in NPC com-
position is required for both myogenic and neuronal
differentiation. The transmembrane nucleoporin
Nup210 is absent in proliferating myoblasts and
embryonic stem cells (ESCs) but becomes ex-
pressed and incorporated into NPCs during cell
differentiation. Preventing Nup210 production by
RNAi blocks myogenesis and the differentiation of
ESCs into neuroprogenitors. We found that the
addition of Nup210 to NPCs does not affect nuclear
transport but is required for the induction of genes
that are essential for cell differentiation. Our results
identify a single change in NPC composition as an
essential step in cell differentiation and establish
a role for Nup210 in gene expression regulation and
cell fate determination.
INTRODUCTION
Nuclear pore complexes (NPCs) are large multiprotein channels
that penetrate the nuclear envelope (NE) at sites where the inner
and the outer nuclear membranes are fused. Because NPCs are
the sole gateway between the nucleus and the cytoplasm, it has
been historically assumed that their main and only function is to
regulate nucleocytoplasmic transport (Wente and Rout, 2010).
It has now become evident, however, that NPCs are highly dy-
namic complexes with many transport-independent functions
such as chromatin organization and gene regulation (D’Angelo
and Hetzer, 2008; Strambio-De-Castillia et al., 2010).
Only three of the NPC components, Pom121, NDC1, and
Nup210, are integral membrane proteins. These proteins have
been proposed to anchor the NPC to the NE and to initiate
nuclear membrane fusion during nuclear pore assembly (Antonin
et al., 2005; Doucet et al., 2010; Stavru et al., 2006a, 2006b).
Increasing evidence supports the role of Pom121 and NDC1 in446 Developmental Cell 22, 446–458, February 14, 2012 ª2012 Elsevthese processes. However, the function of Nup210 at the NPC
is less clear. Nup210 is recruited late during nuclear pore
assembly and exhibits cell-type-specific expression, indicating
that it is not required for NPC formation (Bodoor et al., 1999;
Olsson et al., 2004). Additionally, Nup210was found to be impor-
tant for NE breakdown in C. elegans (Galy et al., 2008), but the
absence of Nup210 in several mammalian cell types suggests
that its role in NE breakdown is not universally conserved.
Thus, the function of Nup210 and the physiological significance
of its tissue-specific expression remain to be determined.
The expression of several NPC components has recently been
shown to vary among different cell types and tissues (Cho et al.,
2009; Guan et al., 2000; Olsson et al., 2004), and also during
development (D’Angeloet al., 2009; Lupuet al., 2008). Thesefind-
ings, together with the fact that mutations in certain NPC compo-
nents result in tissue-specific diseases (Basel-Vanagaite et al.,
2006;CronshawandMatunis, 2003;Neilsonet al., 2009), suggest
that NPC composition may play an important cellular function.
Yet, whether different cell types have pores of different com-
position, and the importance of such variations, is uncertain.
Here we show that the expression of Nup210 is induced during
myogenic and neural differentiation, and that the addition of this
nucleoporin to NPCs is required for the differentiation process.
Interestingly, our data show that Nup210 recruitment to the
NPC does not affect nucleocytoplasmic transport or the target-
ing of inner nuclear membrane proteins (INMPs) to the NE. Using
genome-wide expression analysis, we found that Nup210 regu-
lates myogenesis through changes in the expression patterns of
genes involved in differentiation. Remarkably, the ectopic
expression of Nup210 is sufficient to increase the mRNA levels
of these genes and to accelerate myoblast differentiation. Our
results indicate that a single change in NPC composition is
required for cell differentiation along two distinct lineages, and
point toward nuclear pore specification as a key regulator of
developmental gene expression.
RESULTS
Nup210 Expression Is Induced during
Myogenic Differentiation
Using the well-characterized C2C12 in vitromyogenicmodel, we
have recently reported changes in the gene expression profiles
of several pore components during myoblast differentiation
(D’Angelo et al., 2009). Briefly, we found that most scaffold nu-
cleoporins were strongly downregulated during cell-cycleier Inc.
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Figure 1. Nup210 Expression Is Induced during Myogenic Differentiation
(A) mRNA and protein levels of Nup210 during C2C12 differentiation were analyzed by qPCR and western blot, respectively (n = 3). Nup210 mRNA levels in
differentiating cells were normalized to the expression of dividing cells (day 0). MHC was used as a differentiation marker and histone H3 (His H3) as loading
control. Data are presented as average values ± SD.
(B) Nup210 mRNA and protein levels in dividing myoblasts (M), differentiated C2C12 cells (D), myotubes (T), and quiescent myoblasts (Q) were analyzed by
semiquantitative PCR and western blot, respectively.
(C) Immunofluorescence against Nup210 and Pom121 in dividing and differentiated (day 4) C2C12 cells. MHC was used as a maker for differentiated myotubes,
and nuclei were stained with Hoechst.
(D) Higher magnification of immunofluorescence against Nup210 and Pom121. Arrowheads indicate quiescent myoblasts.
See also Figure S1.
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their expression levels. By expanding our analysis to include all
Nups, we found that the transmembrane nucleoporin Nup210
was the only NPC component that was absent in proliferating
myoblasts but strongly expressed during myogenic differentia-
tion (Figure 1A; see also Figure S1 available online). During
C2C12 differentiation, a portion of myoblasts remain as quies-
cent cells that do not differentiate and maintain the potential to
reenter the cell cycle when exposed to growth factors. To deter-
mine whether Nup210 induction occurs during differentiation or
upon cell-cycle exit, myotubes were separated from nondividing
quiescent cells, and Nup210 mRNA and protein levels were
analyzed in each fraction. We found that Nup210 was only
detectable in postmitotic myotubes (Figure 1B). This differential
expression was also evident in immunofluorescence assays.
Although Pom121, another transmembrane Nup, was detected
in the NE of every cell before and after differentiation, Nup210
signal was restricted to postmitotic nuclei and was absent in
proliferating and quiescent myoblasts (Figures 1C and 1D).
These results suggest that the expression of Nup210 occurs
during myoblast differentiation. Furthermore, Nup210 expres-
sion is induced after Myogenin (Figure S1A), an early regulator
of myogenic differentiation, and sequence analysis of the
Nup210 promoter identified two classical myogenin binding sitesDevelopm(data not shown), suggesting that Nup210 is a downstream
target of this transcription factor.
Depletion of Nup210 during Differentiation Inhibits
Myotube Formation In Vitro
Next we wanted to determine whether the induction of Nup210
expression was required for cell differentiation. To test this, we
generated stable knockdown cell lines by infecting proliferating
myoblasts with lentivirus carrying control or Nup210-specific
shRNAs (Figure S2A). As expected from the lack of Nup210
expression in dividing myoblasts, the presence of the Nup210
shRNA had no effect on myoblast proliferation or survival (Fig-
ure S2B). However, preventing Nup210 induction during differ-
entiation resulted in a strong inhibition of myotube formation
(Figures 2A–2C, S2C, and S2D). The lack of Nup210 under differ-
entiation conditions resulted in fewer cells positive for the
myogenic marker myosin heavy chain (MHC). Most of these cells
did not progress in the differentiation process and remained in
the mononucleated stage (Figures 2A–2C and S2D), suggesting
that cells were able to exit the cell cycle but failed to initiate cell-
cell fusion, a later event in muscle differentiation. Depleting
Nup210 was also associated with increased cell mortality likely
due to the activation of the apoptotic pathway as judged by acti-
vated caspase-3 staining (Figure S2E). A similar inhibition ofental Cell 22, 446–458, February 14, 2012 ª2012 Elsevier Inc. 447
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Figure 2. Nup210 Is Required for Myoblast Differentiation
(A) C2C12 cells were infected with lentivirus carrying control or Nup210-specific shRNAs. Infected cells were selected and induced to differentiate. Differentiated
myotubes were stained against MHC at 48, 72, and 96 hr after differentiation. Nuclei were stained with Hoechst.
(B) The percentage of nuclei in multinucleated cells (>2 nuclei) to the total number of nuclei in the field (fusion index) in (A) was quantified. Values represent the
average of four different independent experiments ± SD.
(C) Quantification ofMHC-positive cells shown in (A). Percentage of cells containing one (mononucleated), two (binucleated), or more nuclei (multinucleated) were
determined at different times of differentiation. Data are presented as average values of three independent experiments.
(D) C2C12 cell lines carrying control or Nup210 shRNAs were transfected with GFP or an RNAi resistant Nup210-GFP (rNup210-GFP). Cells were reselected,
induced to differentiate and stained against MHC on day 4. Insets show a higher magnification of GFP and Nup210-GFP expressing cells.
(E) Fusion index for the experiment in (D) was quantified as described.
See also Figure S2.
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Developmental Change in Nuclear Pore Compositionmyoblast differentiation was observed when using an shRNA
directed to Nup210 30 untranslated region (Figure S2F). In
contrast, downregulation of the other transmembrane nucleo-
porins Pom121 and NDC1 had no effect on differentiation,
indicating that the observed inhibition was specific to Nup210
depletion (Figure S2G).
To further verify the specificity of the Nup210 knockdown,
we performed Nup210 rescue experiments. Stable cell lines448 Developmental Cell 22, 446–458, February 14, 2012 ª2012 Elsevcarrying control or Nup210 shRNAs were transfected with
a plasmid encoding either GFP or a Nup210-GFP fusion
resistant to RNAi (rNup210-GFP). These cells were reselected,
and their ability to differentiate was tested. As shown in Figures
2D and 2E, myoblasts expressing rNup210-GFP but not GFP
alone were able to differentiate into multinucleated myotubes,
confirming the essential role of Nup210 in the myogenic
process.ier Inc.
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Figure 3. NPC-Associated Nup210 Does Not Affect INMP Targeting or Global Nucleocytoplasmic Transport
(A) Postmitotic myotubeswere fractionated by sequential centrifugation, and Nup210 protein levels were analyzed in the different subcellular fractions bywestern
blot. C, cytoplasm; N, nucleus; E/G, endoplasmic reticulum/Golgi; PM, plasma membrane.
(B) Nup210 localization in postmitotic myotubes was analyzed by immunofluorescence. MHC was used as a marker of differentiation and mAb414 as a marker
for NPCs.
(C) Colocalization of Nup210 and mAb414 signals at the NE was determined using ImageJ.
(D) C2C12 myoblasts were transfected with Emerin-V5, V5-Lap2B, Lem2-V5, and V5-Man1 and induced to differentiate. Cells were infected with lentivirus
carrying control or Nup210 shRNAs at 36 hr after differentiation and stained for Nup210 and V5 at 96 hr postinfection. Insets show higher magnification of
myotube nuclei.
(E) C2C12myoblasts were transfected with NES-Tomato-NLS and Lamin A-EGFP and induced to differentiate. Cells were infected with lentivirus carrying control
or Nup210 shRNAs at 36 hr after differentiation, and nuclear transport was analyzed by FRAP of NES-Tomato-NLS 96 hr postinfection. Values represent the
average of three different independent experiments ± SD.
See also Figures S3 and S4.
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Developmental Change in Nuclear Pore CompositionNup210 Functions at the NPC of Myotubes
Nup210 is a transmembrane nucleoporin with a long lumenal
domain, a single transmembrane segment, and a short 55 amino
acid nuclear/cytoplasmic tail, a structure that resembles that of
viral membrane fusion proteins (Figure S3A) (Greber et al.,
1990). Therefore, it was possible that a fraction of Nup210 could
function as a fusogenic protein at the plasma membrane. To
investigate this, postmitotic myotubes were fractionated by
sequential centrifugation, and the presence of Nup210 in the
different fractions was analyzed by western blot. Like the NE
marker Lamin A, Nup210 was only detected in the nuclear frac-
tion (Figure 3A). In immunofluorescence studies, we found that
endogenous Nup210 was specifically located at the NPC, coloc-
alizing with other pore components, and not present at theDevelopmplasma membrane (Figures 3B and 3C). Furthermore, exoge-
nously expressing Nup210-GFP in myoblasts resulted in its
localization to the NE and, at high expression levels, also to the
ER but was undetectable at the cell surface (Figure S3B). These
results indicate that endogenous Nup210 is present only at the
NE and regulates myogenic differentiation through its associa-
tion with NPCs.
Nup210 Depletion Does Not Affect Targeting of INMPs
Microinjection of antibodies against the cytoplasmic domain of
Nup210 in HeLa cells has been shown to block the passage of
an INMP reporter through the nuclear pore (Ohba et al., 2004).
Interestingly, several INMPs have been shown to be required
for myogenic differentiation (Huber et al., 2009; Kandert et al.,ental Cell 22, 446–458, February 14, 2012 ª2012 Elsevier Inc. 449
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Developmental Change in Nuclear Pore Composition2009), suggesting that Nup210 could be acting by regulating the
transport or accumulation of INMPs. To directly investigate
whether Nup210 depletion affected the localization of INMPs,
we transfected proliferating myoblasts with vectors expressing
V5-Tagged Emerin, Lem2, and MAN1, proteins known to play
a role in C2C12 differentiation; or Lap2b, which is not required
for this process. Myoblasts were then induced to differentiate,
and the postmitotic myotubes were infected with lentivirus
carrying control or Nup210 shRNAs. The distribution of the
INMPs in Nup210-depleted myotubes was then analyzed by
immunofluorescence using an a-V5 antibody. Infected postmi-
totic cells showed decreased levels of Nup210 at 48–72 hr post-
infection and induced an apoptotic response by 96–120 hr
(Figures S3C–S3E), indicating that Nup210 expression is also
required for the maintenance of the differentiated state. When
infected myotubes were stained with the V5 antibody, no differ-
ences in the localization or intensity of the four INMPs were
observed compared to control cells (Figure 3D). More impor-
tantly, we found that unlike the depletion of INMPs (Datta
et al., 2009; Huber et al., 2009), downregulation of Nup210
before differentiation did not prevent myoblast cell-cycle exit
or the induction of early muscle transcription factors such asmy-
ogenin (Figures S3F and S3G). These results suggest that
Nup210 does not regulate the transport or accumulation of
INMPs at the NE, and indicate that the initial steps ofmyogenesis
are properly executed in the absence of this nucleoporin.
Depletion of Nup210 Does Not Affect Global Nuclear
Transport Rates
A primary function of the NPC is to regulate the passage of mole-
cules between the nucleus and the cytoplasm (D’Angelo and
Hetzer, 2008). A previous study reported that antibodies against
the lumenal domain of Nup210 affect NLS-dependent nuclear
protein import (Greber and Gerace, 1992). We therefore investi-
gated whether Nup210 recruitment to the NPC would affect
general nucleocytoplasmic transport. Proliferating myoblasts
were transfected with the transport reporter NES-Tomato-NLS
and the NE marker Lamin A-GFP, induced to differentiate and
then infected with lentivirus carrying control or Nup210 shRNAs
as previously described. Nuclear transport was measured in
postmitotic myotubes 72 hr after infection by photobleaching
the intranuclear reporter signal and measuring its recovery
over time. Although Nup210 levels at the NE were strongly
reduced in infected myotubes (Figure S4A), no difference in
nuclear import rates was observed between control and
Nup210 knockdown cells (Figure 3E). Alterations in nuclear
export can also be detected using this reporter because they
lead to changes in its intranuclear accumulation (Figure S4B).
Yet, no changes in the nuclear accumulation of the transport
reporter were observed between control and Nup210-depleted
cells, indicating that Nup210 knockdown does not affect nuclear
export (Figure S4C). Altogether, these results suggest that
Nup210 does not regulate myogenesis through major changes
in nucleocytoplasmic transport.
Nup210 Regulates the Expression of Genes Essential
for Cell Differentiation
NPCs have been recently shown to play an important role in gene
expression regulation of higher eukaryotes (Capelson et al.,450 Developmental Cell 22, 446–458, February 14, 2012 ª2012 Elsev2010; Yi et al., 2002). In the absence of evidence for a role of
Nup210 in nuclear transport, we hypothesized that Nup210
might control the expression of genes relevant for myoblast
differentiation. To address this possibility, we infected myotubes
with control or Nup210 shRNA lentiviral particles and analyzed
whole-genome gene expression at 48 or 72 hr postinfection,
when Nup210 expression was at least 4-fold downregulated,
but cell viability was not significantly affected. Of the 255 known
genes that showed a greater than 1.5-fold change (p < 0.05)
between control and Nup210 knockdown, 64 genes were tran-
scriptionally upregulated, whereas 191 genes were reduced
(Figure 4A; Table S1).
Upregulated genes were notably enriched (20%) for cell-
cycle/cell-growth-related genes (Table 1). Immunofluorescence
analysis of Cyclin A at 96 hr postinfection showed that the induc-
tion ofCyclin A by Nup210 RNAi occurred in quiescent cells, and
not in postmitotic tubules (data not shown), suggesting that
quiescent cells try to reenter the cell cycle as Nup210-depleted
myotubes are lost. This is supported by the findings that physi-
cally removing myotubes from differentiated C2C12 cultures
induces the activation of Cyclin A expression in quiescent cells
(Figure S5A). These results support the hypothesis that
Nup210 does not affect myoblast cell-cycle exit and is not
required for the early steps of myogenesis.
Conversely, downregulated genes showed a significant
enrichment (17%) in cell differentiation and development genes
(Table 1). Among these genesAsb2,Cand2,Clic5,GDF5, Igfbp4,
Neu2, Ndrg2, and Stra13 have been directly linked to myogene-
sis and skeletal system development. For example, increased
expression of Clic5 and Neu2 in C2C12 cells results in acceler-
ated myotube formation (Fanzani et al., 2003; Li et al., 2010).
Additionally, Asb2 promotes myogenesis by inducing the ubiqui-
tin-dependent degradation of the actin binding protein filamin B
(Corte´s et al., 2010), whereas Stra13 and Cand2 regulate myo-
genesis by inhibiting NOTCH signaling and suppressing the
ubiquitination/degradation of myogenin, respectively (Shiraishi
et al., 2007; Sun et al., 2007). In contrast, Igfbp4 has been sug-
gested to play a negative role during myoblast differentiation
(Damon et al., 1998; Foletta et al., 2009), and GDF5 involvement
in this process remains unclear. Using quantitative PCR (qPCR),
we confirmed that the transcriptional activity of these eight
genes decreased with Nup210 downregulation (Figure S5B)
and that their expression, with the exception ofStra13, increased
during myogenic differentiation (Figure 4B).
Among these eight genes, only the role of GDF5 in C2C12
differentiation was previously uncharacterized. We therefore
tested whether its downregulation would affect myogenesis.
We predicted that if GDF5 was downstream of Nup210 in the
differentiation process, depletion of GDF5 should also inhibit
myotube formation. To address this, we generated stable cell
lines expressing control shRNA, GDF5 shRNA, or Neu2 and
Clic5 shRNAs, which as mentioned had been already suggested
to play a role inmyoblast differentiation, and analyzed their ability
to differentiate. Strikingly, reduced levels of the three genes
resulted in a strong inhibition of myotube formation (Figures 4C
and S5C), indicating a positive role for these factors in myogenic
differentiation. The inhibition of myoblast differentiation for each
single gene was weaker than the inhibition observed with
Nup210 depletion, particularly for Clic5, supporting a model inier Inc.
A CControl Nup210 KD
UP
D
O
W
N
Standardized intensity
-1.9                          0                        1.9
B
0
200
400
600
800
1000
1200
0 1 2 3 4 5 6
m
R
N
A 
le
ve
ls
Differentiation day
Nup210 GDF5 Clic5
0
5
10
15
20
25
30
35
0 1 2 3 4 5 6
m
R
N
A 
le
ve
ls
Differentiation day
Cand2 Igfbp4
0
0.5
1
1.5
2
2.5
0 1 2 3 4 5 6
m
R
N
A 
le
ve
ls
Differentiation day
Stra13 NDGR2
0
20
40
60
80
100
120
140
0 1 2 3 4 5 6
m
R
N
A 
le
ve
ls
Differentiation day
Asb2 Neu2
Co
nt
ro
l
G
DF
5 
N
eu
2
N
up
21
0
Cl
ic
5 
48h 72h 96h
Differentiation time 
sh
R
N
A
Figure 4. Nup210 Regulates Gene Expression in Postmitotic Myotubes
(A) C2C12 cells were infected with lentivirus carrying control or Nup210 shRNAs at 36 hr after differentiation, and whole-genome expression was analyzed by
microarray. Heat map shows the microarray expression profile of altered expression in Nup210 knockdown myotubes. See also Table 1 and Table S1.
(B) The expression ofNup210,GDF5,Clic5,Asb2,Neu2,Cand2, Igfbp4,Stra13, andNDRG2 duringmyoblast differentiation was analyzed by qPCR.mRNA levels
in differentiating cells were normalized to the levels of dividing cells. Values represent average ± SD of three different independent experiments.
(C) C2C12 myoblasts were infected with lentivirus carrying control, Clic5, GDF5, Neu2, or Nup210 shRNAs and induced to differentiate. Immunofluorescence
against MHC was performed at 48, 72, and 96 hr postdifferentiation.
See also Figure S5.
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Developmental Change in Nuclear Pore Compositionwhich Nup210 regulates myogenesis by simultaneously control-
ling the expression of several genes critical for cell differentiation
and/or the maintenance of the differentiated state.
Overexpression of Nup210 Accelerates
Myoblast Differentiation
The ectopic expression of critical master myogenic regulatory
factors such as MyoD has been shown to be sufficient to induce
the expression of muscle differentiation genes and trigger
muscle formation. The finding that Nup210 depletion resulted
in the downregulation of critical myogenic genes prompted us
to investigate whether its overexpression in myoblasts was suffi-
cient to activate these genes in the absence of differentiation
conditions. To test this, we generated stable C2C12 cell lines
expressing GFP or a Nup210-GFP fusion under a constitutively
active CMV promoter (Figure S6A). Total RNA was isolated
from control and Nup210-GFP expressing cells, and the mRNA
levels for the previously identified genes were quantified by
qPCR. We found that five of the eight genes were upregulatedDevelopmby exogenously expressing Nup210 (Figure 5A), suggesting
that Nup210 is sufficient to induce the expression of develop-
mentally regulated genes. Strikingly, the ectopic expression of
Nup210 accelerated the formation of myotubes (Figures 5B–
5D). Accelerated differentiation was evident as early as 12 hr
after differentiation (Figures S6B and S6C), and Nup210 overex-
pression was able to induce tubule formation in confluent
myoblasts grown in high-serum, growth factor-rich, conditions
that normally do not trigger myoblast fusion (Figure S6D). This
phenotype required the full-length Nup210 protein because
myoblasts expressing either the lumenal N-terminal domain or
the cytoplasmic/nuclear C-terminal domain of Nup210 showed
a strong inhibition of myoblast differentiation (Figure S6E). The
dominant-negative effect of these fragments indicates that
both domains of Nup210 are essential for its function and further
confirms the direct role of this nucleoporin in myogenesis. The
accelerated myogenic phenotype of Nup210 overexpression
resembles that of Clic5 and Neu2 overexpression (Fanzani
et al., 2003; Li et al., 2010), and supports the idea that Nup210ental Cell 22, 446–458, February 14, 2012 ª2012 Elsevier Inc. 451
Table 1. Selected Genes Affected by Nup210 Depletion in Postmitotic Myotubes
Gene Symbol Accession Number Fold-Change p Value Function
Up
Hist1h3d NM_178204 1.99 0.0003 Nucleosome remodeling in cell cycle
Psrc1 NM_019976 1.86 8 E-05 Mitosis progression, spindle dynamics regulation
Hgf NM_178204 1.85 0.0004 Proliferation, cell growth, and cell motility
Ccnb1 NM_010427 1.62 0.0061 Regulation of cell cycle
Casc5 NM_024245 1.63 0.0040 Spindle assembly and chromosome alignment
Mki67 NM_001081117 1.62 0.0048 Cell proliferation
Kif11 NM_001081117 1.58 0.0158 Chromosome positioning, centrosome separation,
and bipolar spindle assembly in mitosis
Bub1 NM_009773 1.55 0.0118 Mitotic spindle assembly checkpoint, kinetochore assembly
Ccna2 NM_009828 1.54 0.0136 Cell-cycle regulation
Knl2 NM_172578 1.54 Chromosome segregation during mitosis
Kif23 NM_024245 1.54 0.0022 Cell-cycle progression, cytokinesis.
Mad2l1 NM_019499 1.53 0.0005 Mitotic spindle assembly checkpoint
Parp14 NM_001039530 1.50 0.0019 Survival of injured proliferating cells
Down
Nkd2 NM_028186 2.54 0.0004 Development regulation through Wnt signaling
Tmem119 NM_146162 2.19 0.0002 Promotes osteoblast differentiation
L1cam NM_008478 2.18 5 E-05 Nervous system development, neuronal migration, and differentiation
Gpr56 NM_018882 1.95 0.0007 Testis and nervous system development
Kpna3 NM_008466 1.90 2 E-06 Development regulation through Wnt signaling, spermatogenesis
Neu2 NM_001160165 1.90 0.0013 Myogenic differentiation
Grhl3 NM_001013756 1.89 0.0021 Epidermal differentiation
Wnt10a NM_009518 1.86 0.0014 Limb development, cartilage and odontoblast differentiation
Nefl NM_010910 1.85 0.0026 Nervous system development
Ablim3 NM_198649 1.79 0.0049 Embryonic development, cell lineage determination
Ndrg2 NM_013864 1.76 0.0128 Myoblast proliferation and neural differentiation
Crim1 NM_015800 1.74 0.0011 Nervous system development
Cmklr1 NM_008153 1.74 1 E-05 Regulates adipogenesis and osteoblastogenesis
Apobec2 NM_009694 1.73 1 E-06 Stem cell differentiation
Mfap5 NM_015776 1.72 0.0014 Angiogenesis
Mir145 NR_029557 1.70 0.0003 Growth arrest and differentiation
Edn1 NM_010104 1.69 0.0004 Nervous system development
Nox4 NM_015760 1.68 0.0072 Myofibroblast, osteoblast and chondrogenic differentiation, angiogenesis
Gdf5 NM_008109 1.67 0.0007 Limb morphogenesis, embryonic cell differentiation,
skeletal and joint development
Stra13 NM_016665 1.66 3 E-08 Satellite cell activation, myogenic and trophoblast differentiation
Clic5 NM_172621 1.64 0.0018 Myoblast proliferation and differentiation
Igfbp4 NM_010517 1.64 0.0115 Inhibitor of myoblast differentiation
Camk2a NM_177407 1.63 8 E-05 Nervous system development, osteoblast differentiation
Asb2 NM_023049.1 1.62 5 E-05 Muscle differentiation
Rrad NM_019662 1.59 5 E-05 Stem cell differentiation
Tspan12 NM_173007 1.57 1 E-05 Vascular development
Cand2 NM_025958 1.56 0.0008 Myogenic differentiation
Fam136a BC103775 1.55 3 E-05 Gastrointestinal development
Wnt10b NM_011718 1.54 0.0026 Skeletal development, epithelial and osteoblast differentiation, adipogenesis
Noxp20 NM_026667 1.53 0.0001 Neuronal differentiation
Bmp2k NM_080708 1.5 6 E-05 Osteoblast differentiation
Ptprf NM_011213 1.5 0.0002 Adipogenic, thymocyte differentiation, nervous system development
Bold type indicates genes that were further analyzed in this study.
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Figure 5. Ectopic Expression of Nup210 in Myoblasts Increases the Expression Levels of Differentiation Genes and Accelerates Myotube
Formation
(A) The expression levels of Asb2, Clic5, GDF5, Neu2, and Ndrg2 in GFP and Nup210-GFP expressing myoblasts were analyzed by qPCR. mRNA levels for each
gene was normalized to the levels of GFP-expressing cells. Values represent average ± SD of three different independent experiments.
(B) GFP and Nup210-GFP C2C12-expressing myoblasts were induced to differentiate. Immunofluorescence against MHC was performed at 48, 72, and 96 hr
postdifferentiation.
(C) Fusion index (percentage of nuclei inmultinucleated cells [>2 nuclei] to the total number of nuclei in the field) for experiment in (B). Values represent the average
of four different independent experiments ± SD.
(D) Percentage of cells containing 1–4, 5–10, 11–20, or >20 nuclei in (B) was determined at different times of differentiation. Data are presented as average values
of three independent experiments.
(E) C2C12 myoblasts ectopically expressing Nup210-GFP were infected with lentivirus carrying control, Clic5, GDF5, or Neu2 shRNAs and induced to differ-
entiate. Immunofluorescence against MHC was performed at 24, 48, and 72 hr postdifferentiation. GFP overlay shows the expression of Nup210-GFP.
See also Figure S6.
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Developmental Change in Nuclear Pore Compositionacts upstream of these genes. To test this hypothesis, we deter-
mined the effect of depleting GDF5, Neu2, and Clic5 on the
differentiation of C2C12 cells overexpressing Nup210. We found
that downregulation of Neu2 and GDF5 completely blocked the
acceleration of myogenesis by this nucleoporin, confirming that
these are downstream targets of Nup210 (Figure 5E). Depletion
of Clic5, on the other hand, did not significantly inhibit Nup210
induction of myotube formation. Because Clic5 is strongly
upregulated in Nup210-overexpressing cells (Figure 5A), it is
possible that remaining levels of this protein after knockdown
are sufficient to maintain the differentiation properties of the
Nup210-expressing cell line. An alternative explanation is thatDevelopmNup210 overexpression induces the activity of other myogenic
genes that can compensate Clic5 depletion. Taken all together,
these findings demonstrate that Nup210 acts as an upstream
regulator of key cell differentiation genes and indicate that its
expression is sufficient to accelerate myogenic differentiation.
Nup210 Regulates the Differentiation of Embryonic
Stem Cells into Neuroprogenitors
Nup210 was originally identified for its differential expression
during metanephric epithelial differentiation (Olsson et al.,
1999). In addition, Nup210 has a tissue-specific expression,
with higher levels in kidney, skin, lung, gut, pancreas, and brainental Cell 22, 446–458, February 14, 2012 ª2012 Elsevier Inc. 453
Figure 6. Nup210 Is Essential for Neuronal Differentiation
(A) ESCs were induced to differentiate into NP cells and stained for Nup210. Oct4 and Nestin were used as specific markers for ESCs and NP cells, respectively.
Hoechst was used to stain nuclei.
(B) ESCs were infected with lentivirus carrying control or Nup210 shRNAs and induced to differentiate into NP cells. Differentiated cells were stained against
Nup210 and Nestin. Hoechst was used to stain nuclei.
(C) Differentiated NP cells were infected with lentivirus carrying control or Nup210 shRNA and stained against Nup210 and Nestin.
(D) Control or Nup210 knockdown NP cells were stained with Nestin and Cleaved Caspase-3 (Caspase 3) antibodies.
(E) Schematic model of Nup210 regulation of cell differentiation. In undifferentiated myoblast the expression of Nup210 is repressed. Early differentiation signals
activate Nup210 gene expression. In myoblast, Nup210 induction is likely carried out by myogenin/MyoD binding to its promoter E boxes. Nup210 protein is then
recruited to the NPC where it regulates the expression of genes required for myogenic and neuronal differentiation. Prevention of Nup210 addition to the NPC by
shRNAs prevents the activation of Nup210-regulated genes and leads to the death of the differentiation-committed cell by apoptosis.
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our genome-wide expression analysis, such as Grhl3 and
Wnt10b, play a role in epithelial differentiation, whereas others
like Nefl, Crim1, L1CAM, NOXP20, and Wnt10a are involved in
neuronal development. This raised the question of whether
Nup210 might be involved in other differentiation processes.
To test this hypothesis, we utilized the highly characterized
ESC to neuroprogenitor (NP) cell differentiation system. Briefly,
ESCs of the Hb9-GFP line were induced to differentiate into
NP cells, and the expression of Nup210 was analyzed by immu-
nofluorescence. Consistent with our findings using themyogenic
model, Nup210 was not present in ESCs but was strongly
expressed in NPs (Figure 6A). These findings are in agreement
with a previous genome-wide study in which Nup210 mRNA
levels were reported to increase during ESC to NP cell differen-454 Developmental Cell 22, 446–458, February 14, 2012 ª2012 Elsevtiation (Bain et al., 2000). To investigate whether Nup210 was
also required for NP cell differentiation, we infected ESCs with
lentivirus carrying control or Nup210 shRNAs and evaluated their
ability to differentiate. Depletion of Nup210 did not affect stem
cell survival (data not shown) but strongly inhibited differentiation
into NPs (Figure 6B). Under differentiation conditions, the
absence of Nup210 was associated with strong cell death and
a reduced number of Nestin (a NP marker)-positive cells (Fig-
ure 6B). In agreement with our observations in myotubes, deple-
tion of Nup210 in already differentiated NP cells resulted in cell
death, likely through activation of the apoptotic pathway (Figures
6C and 6D). Altogether, these results indicate that the expression
of Nup210 is essential for neural differentiation and the mainte-
nance of the NP state, and confirm that Nup210 plays a critical
role in diverse cellular differentiation processes.ier Inc.
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Our data provide direct evidence for the existence of cell-type-
specific NPCs and indicate that a single change in NPC compo-
sition is sufficient to regulate a complex cellular process such as
cell differentiation. At the functional level, the transmembrane
nucleoporin Nup210 is activated in a differentiation-dependent
manner and acts to induce the expression of downstream
targets. The finding that Nup210 addition to the NPC is required
for two distinct differentiation processes indicates that this
nucleoporin is a key regulator of cell fate determination, and
further supports the idea that the NPC plays a critical role in
organismal development.
Our findings suggest that cells employ NPCs of different
composition to regulate diverse cellular processes. Considering
that the NPC is built by multiple copies 30 proteins, we can
envision that unique combinations of nucleoporins will result in
NPCs with different functionality. Supporting the existence of
NPCs of different composition/function, the expression of
several nucleoporins has been shown to be cell-type-specific
and/or to vary among different tissues (Cho et al., 2009; Guan
et al., 2000; Lupu et al., 2008; Olsson et al., 2004). Furthermore,
mutations in at least four nucleoporins, Aladin, Nup62, Nup155,
and Nup358, give rise to diseases with tissue-specific pheno-
types (Basel-Vanagaite et al., 2006; Cronshaw and Matunis,
2003; Neilson et al., 2009; Zhang et al., 2008). Finally, studies
in transgenic knockout animals have shown that the depletion
of several nucleoporins specifically affects the function of
distinct tissues or cells (de Jong-Curtain et al., 2009; Faria
et al., 2006; Lupu et al., 2008; Smitherman et al., 2000). The
existence of cell-type-specific nuclear pores was previously
suggested in a study where the tissue-specific expression of
the scaffold nucleoporin Nup133 was determined by in situ
hybridization (Lupu et al., 2008). Although this is an interesting
finding, it was recently shown that the lack of gene expression
for scaffold nucleoporins does not necessarily reflect their
absence from NPCs and might not be a suitable measurement
for tissue-specific nuclear pores (D’Angelo et al., 2009). In this
work, it was found that the expression of Nup133 and other
scaffold Nups is also cell-type specific in developing C. elegans
embryos and even absent in adult worms; but despite the lack
of gene expression, the scaffold proteins are still present in
all embryonic and adult cells (D’Angelo et al., 2009). This indi-
cates that the NPC scaffold components are extremely stable
proteins that remain incorporated at NPCs even when their
expression is strongly downregulated.
Work from our laboratory and others has shown that the NPC
and its components bind and regulate the activity of several
genes (Ahmed et al., 2010; Brickner and Brickner, 2010; Capel-
son et al., 2010; Casolari et al., 2004; Kalverda et al., 2010).
Interestingly, the genes that associate with this structure are
highly enriched in developmental genes (Kalverda et al., 2010).
This suggests that the NPC might play an important role in
differentiation and development by regulating the activity of
genes critical for these processes. The identification that
Nup210 regulates myogenesis by controlling the activity of key
muscle differentiation genes supports this model. Interestingly,
we found that depleting Nup210 also affects the activity of
genes involved in neuronal differentiation and that this proteinDevelopmplays an essential role in this process. Our findings support
a model in which early differentiation factors, likely myogenin
in myoblasts, would activate the expression of Nup210 gene
in cells committed to differentiate (Figure 6E). The addition of
Nup210 to the NPC will then regulate the expression of key
genes for specific differentiation processes. This would explain
the tissue-specific expression of Nup210. The lack of Nup210
at the NPCs of differentiation-committed cells will prevent
them to further proceed with the differentiation process and
trigger cell death by apoptosis.
It is not immediately obvious how a transmembrane nucleo-
porin could regulate gene expression. We cannot rule out that
Nup210 mediates a specific transport event that triggers the
expression of it target genes. However, we think this is unlikely
for two reasons. First, we did not observe any changes in general
nucleocytoplasmic transport. Second, only 55 aa of Nup210 are
exposed to interact with the NPC. This makes it unlikely that
Nup210 would reach and change the properties of the pore
transport channel or be able to interact with transport receptors.
One possible mechanism for Nup210 regulation of gene activity
is that its incorporation into the NPC could affect the dynamic
properties of other nucleoporins known to regulate gene expres-
sion in a transport-independent manner. A promising candidate
would be Nup98, a nucleoporin that shuttles between the NPC
and the nucleoplasm in a transcription-dependent manner
(Griffis et al., 2002) and that has been recently shown to regulate
the activity of several developmental genes (Capelson et al.,
2010; Kalverda et al., 2010). Our microarray data show that
75% of the total altered genes we identify are downregulated,
whereas only 25% are upregulated. This suggests that Nup210
is more likely involved in gene expression activation than repres-
sion. This is consistent with the current view of the NPC as a site
of active transcription. Alternatively, Nup210 could recruit and
modulate the activity of gene/chromatin-regulatory factors
and, as a consequence, control gene expression at the NPC.
In support of such a model, it was recently reported that the
Nup155 nucleoporin recruits HDAC4 to the NPC, and that this
association is important for the localization and activity of
specific genes (Kehat et al., 2011). Finally, Nup210 might help
to recruit specific genes to the NPC. The relocation of genes to
the NPC in order to regulate their activity has been described
for a small number of yeast genes (Brickner and Walter, 2004;
Luthra et al., 2007; Taddei et al., 2006; Tan-Wong et al., 2009).
Although NPCs were initially associated with silent chromatin
regions (Feuerbach et al., 2002; Galy et al., 2000), increasing
evidences indicates that they mostly act as a gene-activating
domain (Ahmed et al., 2010; Brickner and Brickner, 2010; Capel-
son et al., 2010; Casolari et al., 2004; Kalverda et al., 2010). A
positive role of the NPC in gene activation is consistent with
our findings that Nup210 depletion is mostly associated with
gene downregulation. Yet, arguing against a role of Nup210 in
gene tethering to the NPC, using fluorescent in situ hybridization,
we have not found changes in the intranuclear localization of
GDF5 and Clic5 genes during myoblast differentiation (data not
shown).
Our findings that Nup210 plays a key role in cell differentiation
provide insights into its functions and address the long-standing
question of what is the biological significance of Nup210 tissue-
specific expression.ental Cell 22, 446–458, February 14, 2012 ª2012 Elsevier Inc. 455
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Semiquantitative RT-PCR and qPCR
C2C12 total RNA and cDNA were prepared with QIAGEN RNeasy and
QuantiTect Rev. Transcription Kits, respectively. qPCR was performed
using SYBR Green. Primers are listed in Supplemental Experimental
Procedures.
Western Blots and Immunofluorescence
For protein extracts, proliferating myoblasts or differentiated myotubes were
resuspended in 1% SDS buffer preheated to 95C, incubated at 95C for
5 min, and passed five to ten times though a 27G syringe. Protein concentra-
tion was determined using the BCA reagent (Pierce), normalized, and 4%
b-mercaptoethanol plus 0.01% bromophenol blue was added. For western
blot analysis 40–80 mg of protein was resolved in SDS-PAGE and transferred
to Immobilon-FL membranes (Millipore). Membranes were blocked with
PBS-0.05% Tween 20 (PBS-T) plus 5% nonfat milk for 1 hr, washed, and incu-
batedwith primary antibody for 1 hr at room temperature (RT) or overnight (ON)
at 4C. The secondary antibody was added after three washes with PBS-T for
1 hr at RT. Membranes were analyzed with an Odyssey infrared imaging
system (LI-COR Biosciences).
For immunofluorescence, myoblasts and myotubes were cultured in 8-well
plates (Ibidi #80826). For Nup210 staining, cells were fixed in20Cmethanol
for 2 min and then permeabilized in 13 PBS/1% Triton X-100 for 1 min. For
MHC, cells were either fixed in methanol when costained with Nup210 or in
4% PFA for 5 min. For all other antibodies and cells, fixation was done in
4% PFA for 5 min. Fixed cells were blocked using IF buffer (13 PBS,
10 mg/ml BSA, 0.02% SDS, 0.1% Triton X-100) and incubated with primary
antibody in IF buffer for 1 hr or at RT or ON at 4C (for Nup210, Nestin and
Oct4 antibodies). Cells were washed in IF buffer and incubated with secondary
antibody for an additional hour at RT. Cells were washed in IF buffer and incu-
bated with Hoechst for 5 min before mounting using VECTASHIELD (Vector
Laboratories). Images were taken with a Leica SP2 confocal microscope
and a Zeiss Axio Observer Z1 motorized microscope.
Rescue Experiment and Nup210 Overexpression
Cell lines expressing control or Nup210 shRNAs were transfected on 6-well
plates at 30% confluency using 16 ml of Optifect and 4 mg of GFP, Nup-
210GFP or rNup210-GFP plasmid DNA. After 48 hr, cells were split into 10 cm
platesandexposed to 1mg/ml ofG418 for 2weeks.Resistant cellswere sorted,
andGFP-positive cells were collected and grown in proliferativemedia contain-
ing 500mg/ml ofG418 formaintenance. Cell lineswere grown in 2 mg/ml of puro-
mycin to maintain knockdown. The same protocol was used to generate the
GFP and Gp210-GFP overexpressing cell lines in wild-type C2C12.
Cell Fractionation
For subcellular fractionation, cells were collected on day 3 after differentiation
and resuspended in 1 vol of fractionation buffer (250 mM sucrose, 20 mM
HEPES [pH 7.4], 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA,
1 mM DTT, protease inhibitors). Cells were placed on ice for 15 min and lysed
with a 27G syringe (five to ten strokes). Subcellular fractions were separated by
sequential centrifugation at 4C as follows: nuclei (7503 g 10 min), mitochon-
dria (5,000 3 g 15 min), ER/Golgi (30,000 3 g 1 hr), and plasma membrane/
microsomes (100,000 3 g 1 hr). After each centrifugation step, pellets were
washed with 1 ml of fractionation buffer and then resuspended in 1% SDS
buffer preheated to 95C, incubated at 95C for 5 min. Protein was quantified
as described, and 10 mg of proteins was used for western blot analysis.
BrdU Incorporation
Approximately 100,000 cells were plated onto 24-well plates. Twenty-four
hours later, cultures were either left in proliferating media or shifted to differen-
tiation media for the times indicated. Cells were incubated in media containing
10 mM BrdU (BD PharMingen; catalog #550891) for 30 min, washed twice in
13 PBS, and fixed for 5 min in 4% PFA at RT. Immunofluorescence against
BrdU was carried out ON at 4C, and samples were counterstained with
Hoechst 33342. Total number and BrdU-positive nuclei were counted manu-
ally by using Count Tool from Adobe Photoshop.456 Developmental Cell 22, 446–458, February 14, 2012 ª2012 ElsevFACS
For sorting, cultures were dissociated with trypsin for 5 min, centrifuged at
1,000 3 g, and resuspended in 13 PBS plus 2% FBS. Positive cells were
collected in 100% FBS and plated on DMEM plus 20% FBS.
shRNA Production, Infection, and Selection
Lentivirus was packaged in 293T cells grown in DMEM plus 20% FBS and
13 penicillin/streptomycin. 293T cells were transfected in 10 cm plates with
5.2 mg of shRNA vector and 2.8 mg of packaging mix using 24 ml of Lipofect-
amine 2000. Media were replaced 12 hr after transfection, and virus was
collected at 36 and 60 hr. Proliferating myoblasts at 30% confluency were
infected with the 36 and 60 hr supernatants 24 hr later. Myoblasts were then
split and cultured in media containing 2 mg/ml of puromycin. For myotube
infections highly concentrated viral stocks (at least 1–5 3 1010 TU/ml) were
generated in the Viral Vector Salk facility. For postmitotic myotube infections
cells were infected with 2 3 108 TU at 36 hr after initiation of differentiation.
INMP Localization and Nuclear Transport Analysis
Wild-type C2C12 cells were transfected at 30% confluency in 8-well plates
(Ibidi #80826) using 4 ml of Optifect (Invitrogen) and 1 mg of DNA. Differentiated
cells were infected with shRNA against scramble and Nup210 KD 36 hr after
shifting the cultures to differentiating media. Samples were fixed and stained
against V5 and Nup210 at 96 and 120 hr postinfection. Images were taken
with a Leica SP2 confocal microscope.
Microarray
For microarray analysis, shRNA-infected myotubes were resuspended in
TRIzol reagent at 48 or 72 hr postinfection. RNA was purified following the
manufacturer specifications, and after the addition of ethanol, 70% of the
RNA was loaded on an RNeasy purification column (QIAGEN) and further
purified following the kit instructions. Before using the RNA for microarray
analysis, Nup210 downregulation was confirmed by qPCR.
For gene expression analysis in Nup210 knockdown, four independent
myotube infections for control and Nup210 shRNA were used. Samples were
comparedusingAffymetrixMouse1.0STarraysasspecifiedby themanufacturer.
Analysis of gene expression was preformed with Partek Genomics Suite
software. RNA background correction, quantile normalization, log2 transfor-
mation, and mean polished probe set summarization were performed to
generate intensity values. Due to the low number of genes affected, gene cate-
gories were mostly poorly defined. Thus, functional categorization of genes
was performed by manually searching the published literature for each gene.
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